Epizyme reported $-62820000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3042M 769M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Amarin AMRN:US $ 1.82M 7.74M
Amgen AMGN:US $ 3228M 40M
Avrobio Inc AVRO:US $ -32246000 1.17M
Biogen BIIB:US $ 991.8M 155.8M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Cerulean Pharma CERU:US $ -12.66M 3.51M
Daiichi Sankyo 4568:JP Y 53261M 7192M
Eisai 4523:JP Y 15346M 49516M
Epizyme EPZM:US $ -62.82M 6.9M
Exelixis EXEL:US $ 56.42M 70.25M
Gilead Sciences GILD:US $ 4370M 1605M
Glaxosmithkline GSK:US $ 3660M 1034M
GlaxoSmithKline GSK:LN 3660M 1034M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Macrogenics MGNX:US $ -50191000 12.69M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Novartis NVS:US $ 4837M 65M
Novartis NOVN:VX SF 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Seattle Genetics SGEN:US $ -281.36M 207.58M
Spectrum Pharmaceuticals SPPI:US $ -33.02M 10.98M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
Xencor XNCR:US $ -39.31M 50.15M